Article Text

Download PDFPDF
Randomised controlled trial
In children and adolescents with mild persistent asthma, daily beclomethasone reduces treatment failure compared with rescue beclomethasone plus albuterol

Statistics from


  • Competing interests TK has received honoraria from AstraZeneca Canada, Nycomed Canada and Merck Frosst Canada.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.